Order Article Reprints

Speer C, Töllner M, Benning L, Bartenschlager M, Kim H, Nusshag C, Kälble F, Reineke M, Reichel P, Schnitzler P, et al. BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study. Viruses. 2023; 15(8):1778. https://doi.org/10.3390/v15081778

Speer, Claudius, Maximilian Töllner, Louise Benning, Marie Bartenschlager, Heeyoung Kim, Christian Nusshag, Florian Kälble, Marvin Reineke, Paula Reichel, Paul Schnitzler, and et al. 2023. "BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study" Viruses 15, no. 8: 1778. https://doi.org/10.3390/v15081778

Speer, C., Töllner, M., Benning, L., Bartenschlager, M., Kim, H., Nusshag, C., Kälble, F., Reineke, M., Reichel, P., Schnitzler, P., Zeier, M., Morath, C., Schmitt, W., Bergner, R., Bartenschlager, R., Lorenz, H.-M., & Schaier, M. (2023). BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study. Viruses, 15(8), 1778. https://doi.org/10.3390/v15081778